• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

声明:一例黄嘌呤结石胱氨酸尿症患者的 SLC3A1 新突变:病例报告。

Declaration: Novel SLC3A1 mutation in a cystinuria patient with xanthine stones: a case report.

机构信息

Department of Urology, The First Affiliated Hospital of Xiamen University, Xiamen, China.

Department of Pediatric Surgery, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, China.

出版信息

BMC Urol. 2023 Jul 31;23(1):130. doi: 10.1186/s12894-023-01300-y.

DOI:10.1186/s12894-023-01300-y
PMID:37525149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10391995/
Abstract

BACKGROUND

Cystinuria and xanthinuria are both rare genetic diseases involving urinary calculi. However, cases combining these two disorders have not yet been reported.

CASE PRESENTATION

In this study, we report a case of cystinuria with xanthine stones and hyperuricemia. The 23-year-old male patient was diagnosed with kidney and ureteral stones, solitary functioning kidney and hyperuricemia after admission to the hospital. The stones were removed by surgery and found to be composed of xanthine.

CONCLUSION

Genetic testing by next-generation sequencing technology showed that the patient carried the homozygous nonsense mutation c.1113 C> A (p.Tyr371*) in the SLC3A1 gene, which was judged to be a functionally pathogenic variant. Sanger sequencing revealed that the patient's parents carried this heterozygous mutation, which is a pathogenic variant that can cause cystinuria. The 24-h urine metabolism analysis showed that the cystine content was 644 mg (<320 mg/24 h), indicating that the patient had cystinuria, consistent with the genetic test results. This case shows that cystinuria and xanthine stones can occur simultaneously, and provides evidence of a possible connection between the two conditions. Furthermore, our findings demonstrate the potential value of genetic testing using next-generation sequencing to effectively assist in the clinical diagnosis and treatment of patients with urinary calculi.

摘要

背景

胱氨酸尿症和黄嘌呤尿症都是罕见的遗传性疾病,涉及尿路结石。然而,尚未有同时合并这两种疾病的病例报告。

病例介绍

本研究报告了一例胱氨酸尿合并黄嘌呤结石和高尿酸血症的病例。该 23 岁男性患者入院后被诊断为肾结石和输尿管结石、孤立肾和高尿酸血症。通过手术取出结石,发现其成分是黄嘌呤。

结论

通过下一代测序技术进行基因检测显示,该患者携带 SLC3A1 基因中的纯合无义突变 c.1113 C>A (p.Tyr371*),该突变被判断为具有功能致病性的变异。Sanger 测序显示,患者的父母携带这种杂合突变,这是一种致病性变异,可导致胱氨酸尿症。24 小时尿液代谢分析显示胱氨酸含量为 644mg(<320mg/24h),表明患者患有胱氨酸尿症,与基因检测结果一致。本病例表明胱氨酸尿症和黄嘌呤结石可同时发生,并为这两种疾病之间可能存在关联提供了证据。此外,我们的发现表明,下一代测序的基因检测具有潜在价值,可有效协助尿路结石患者的临床诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce9/10391995/3c143cc033f3/12894_2023_1300_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce9/10391995/3c143cc033f3/12894_2023_1300_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cce9/10391995/3c143cc033f3/12894_2023_1300_Fig1_HTML.jpg

相似文献

1
Declaration: Novel SLC3A1 mutation in a cystinuria patient with xanthine stones: a case report.声明:一例黄嘌呤结石胱氨酸尿症患者的 SLC3A1 新突变:病例报告。
BMC Urol. 2023 Jul 31;23(1):130. doi: 10.1186/s12894-023-01300-y.
2
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
5
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
6
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.在没有明显临床指征的患者和常见合并症患者亚组中,在择期手术前常规检测全血细胞计数、电解质和尿素以及肺功能测试的价值:对临床和成本效益文献的系统评价。
Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

本文引用的文献

1
Genetics of kidney stone disease.肾结石病的遗传学。
Nat Rev Urol. 2020 Jul;17(7):407-421. doi: 10.1038/s41585-020-0332-x. Epub 2020 Jun 12.
2
Genetic and Clinical Analyses of 13 Chinese Families With Cystine Urolithiasis and Identification of 15 Novel Pathogenic Variants in and .13个胱氨酸尿石症中国家系的遗传与临床分析以及SLC3A1和SLC7A9中15个新致病变异的鉴定
Front Genet. 2020 Feb 18;11:74. doi: 10.3389/fgene.2020.00074. eCollection 2020.
3
Pediatric Cystinuria Patient With Novel Mutation in .患有[具体基因]新突变的小儿胱氨酸尿症患者
Glob Pediatr Health. 2019 Jul 18;6:2333794X19862441. doi: 10.1177/2333794X19862441. eCollection 2019.
4
Clinical, Biochemical, and Genetic Findings of Cystinuria in Chinese Children.中国儿童胱氨酸尿症的临床、生化及遗传学研究结果
Clin Lab. 2018 Jul 1;64(7):1145-1151. doi: 10.7754/Clin.Lab.2018.180110.
5
Conversion from Cystine to Noncystine Stones: Incidence and Associated Factors.胱氨酸结石转化为非胱氨酸结石:发生率及相关因素。
J Urol. 2018 Dec;200(6):1285-1289. doi: 10.1016/j.juro.2018.07.047. Epub 2018 Jul 27.
6
Cystine nephrolithiasis.胱氨酸肾结石病
Transl Androl Urol. 2014 Sep 1;3(3):228-233. doi: 10.3978/j.issn.2223-4683.2014.07.04.
7
The genetic diversity of cystinuria in a UK population of patients.英国患者群体中胱氨酸尿症的基因多样性。
BJU Int. 2015 Jul;116(1):109-16. doi: 10.1111/bju.12894. Epub 2015 Mar 12.
8
Characterization of patients with heterozygous cystinuria.胱氨酸尿症杂合子患者的特征。
Urology. 2012 Oct;80(4):795-9. doi: 10.1016/j.urology.2012.04.062. Epub 2012 Jul 31.
9
Clinical utility gene card for: Cystinuria.胱氨酸尿症临床实用基因卡片
Eur J Hum Genet. 2012 Feb;20(2). doi: 10.1038/ejhg.2011.163. Epub 2011 Aug 24.
10
Management of cystinuria.胱氨酸尿症的管理
Urol Clin North Am. 2007 Aug;34(3):347-62. doi: 10.1016/j.ucl.2007.04.006.